Description
A group II mGluR agonist (Kis = 99 and 94 nM, respectively); inhibits forskolin-stimulated cAMP accumulation in cells expressing human mGluR2 and mGluR3 (EC50s = 5.1 and 24.3 nM, respectively); highly selective for mGluR2 and mGluR3 over mGluR4, mGluR7, mGluR1a, and mGluR5a (EC50s = >100 µM); suppresses electrically stimulated EPSPs in rat striatal neurons in vitro (EC50 = 20 nM); suppresses serotonin-induced EPSCs in rat medial prefrontal cortex in vitro (EC50 = 89.1 nM); attenuates the effects of PCP on working memory, stereotypy, locomotion, and cortical glutamate efflux in a rat model of schizophrenia (10 mg/kg); shows efficacy in animal models of anxiety, epilepsy, and withdrawal from nicotine and morphine
Formal name: (1S,2S,5R,6S)-2-amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid
Synonyms:
Molecular weight: 185.2
CAS: 176199-48-7
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Neuroscience|Behavioral Neuroscience|Anxiety||Research Area|Neuroscience|Behavioral Neuroscience|Schizophrenia & Psychosis||Research Area|Neuroscience|Seizure Disorders
